Rallybio Common Stock Total Equity from 2010 to 2024
| RLYB Stock | USD 1.12 0.03 2.75% |
Common Stock Total Equity | First Reported 2010-12-31 | Previous Quarter 4.6 K | Current Value 3.9 K | Quarterly Volatility 499.2136674 |
Check Rallybio Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rallybio Corp's main balance sheet or income statement drivers, such as Tax Provision of 1.2 K, Net Interest Income of 6.1 M or Interest Income of 6.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.96. Rallybio financial statements analysis is a perfect complement when working with Rallybio Corp Valuation or Volatility modules.
Rallybio | Common Stock Total Equity |
Latest Rallybio Corp's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Rallybio Corp over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Rallybio Corp's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rallybio Corp's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Rallybio Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 3,230 | |
| Geometric Mean | 3,199 | |
| Coefficient Of Variation | 15.46 | |
| Mean Deviation | 368.00 | |
| Median | 3,000 | |
| Standard Deviation | 499.21 | |
| Sample Variance | 249,214 | |
| Range | 1.6K | |
| R-Value | 0.66 | |
| Mean Square Error | 152,367 | |
| R-Squared | 0.43 | |
| Significance | 0.01 | |
| Slope | 73.39 | |
| Total Sum of Squares | 3.5M |
Rallybio Common Stock Total Equity History
About Rallybio Corp Financial Statements
Rallybio Corp stakeholders use historical fundamental indicators, such as Rallybio Corp's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Rallybio Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Rallybio Corp's assets and liabilities are reflected in the revenues and expenses on Rallybio Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Rallybio Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 4.6 K | 3.9 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| AVAV | AeroVironment | |
| ELVN | Enliven Therapeutics | |
| NFLX | Netflix |
Check out the analysis of Rallybio Corp Correlation against competitors. For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rallybio Corp. If investors know Rallybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rallybio Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.79) | Revenue Per Share 0.007 | Return On Assets (0.39) | Return On Equity (0.67) |
The market value of Rallybio Corp is measured differently than its book value, which is the value of Rallybio that is recorded on the company's balance sheet. Investors also form their own opinion of Rallybio Corp's value that differs from its market value or its book value, called intrinsic value, which is Rallybio Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rallybio Corp's market value can be influenced by many factors that don't directly affect Rallybio Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rallybio Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rallybio Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rallybio Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.